The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating National Institutes of Health (NIH) Institutes are inviting grant applications. This vital opportunity seeks to address crucial research needs for developing appropriate pediatric drug formulations, specifically tailored to various age groups. It also strongly encourages the creation and rigorous testing of novel drug delivery systems designed for the unique needs of the pediatric population. The primary objective of this grant is to strategically complement and accelerate, rather than duplicate or compete with, advancements made by the private sector in pediatric drug development. This initiative ultimately aims to significantly enhance the availability of suitable and safe medicines for children.
Opportunity ID: 242014
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-13-346 |
| Funding Opportunity Title: | Development of Appropriate Pediatric Formulations and Drug Delivery Systems STTR (R41) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.173 — Research Related to Deafness and Communication Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 06, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2016 |
| Current Closing Date for Applications: | Sep 07, 2016 |
| Archive Date: | Oct 08, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes within the National Institutes of Health (NIH) encourage grant applications to address different and complementary research needs for the development appropriate pediatric drug formulations in different age groups. This FOA also encourages the development and testing of novel drug delivery systems in the pediatric population. The goal of this FOA is not to duplicate or compete with the private sector but to complement and accelerate the development of appropriate pediatric drugs formulations and drug delivery systems. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-346.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00184851 | Nov 05, 2013 | Sep 07, 2014 | View | |
| FORMS-C | Use for due dates on or after August 5, 2014 | PKG00197143 | Nov 05, 2013 | Jun 08, 2016 | View | |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00224071 | Aug 05, 2016 | Sep 07, 2016 | View |
Package 1
Mandatory forms
242014 RR_SF424_1_2-1.2.pdf
242014 PerformanceSite_1_4-1.4.pdf
242014 RR_OtherProjectInfo_1_3-1.3.pdf
242014 RR_KeyPersonExpanded_1_2-1.2.pdf
242014 RR_Budget-1.1.pdf
242014 RR_SubawardBudget30-1.2.pdf
242014 PHS398_CoverPageSupplement_1_4-1.4.pdf
242014 PHS398_ResearchPlan_1_3-1.3.pdf
242014 PHS398_Checklist_1_3-1.3.pdf
242014 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
242014 PHS_CoverLetter_1_2-1.2.pdf
Package 2
Mandatory forms
242014 RR_SF424_2_0-2.0.pdf
242014 SBIR_STTR_Information_1_1-1.1.pdf
242014 RR_KeyPersonExpanded_2_0-2.0.pdf
242014 RR_OtherProjectInfo_1_3-1.3.pdf
242014 RR_Budget_1_3-1.3.pdf
242014 RR_SubawardBudget30_1_3-1.3.pdf
242014 PerformanceSite_2_0-2.0.pdf
242014 PHS398_ResearchPlan_2_0-2.0.pdf
242014 PHS398_CoverPageSupplement_2_0-2.0.pdf
Optional forms
242014 PlannedReport-1.0.pdf
242014 PHS398_CumulativeInclusionReport-1.0.pdf
Package 3
Mandatory forms
242014 RR_SF424_2_0-2.0.pdf
242014 PHS398_CoverPageSupplement_3_0-3.0.pdf
242014 RR_OtherProjectInfo_1_3-1.3.pdf
242014 PerformanceSite_2_0-2.0.pdf
242014 RR_KeyPersonExpanded_2_0-2.0.pdf
242014 RR_Budget_1_3-1.3.pdf
242014 RR_SubawardBudget30_1_3-1.3.pdf
242014 PHS398_ResearchPlan_3_0-3.0.pdf
242014 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
242014 PHS_Inclusion_Enrollment_Report-1.0.pdf
242014 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
